Ultragenyx is dedicated to supporting impactful projects that benefit the rare disease community, healthcare and STEAM education, and local community efforts. Their commitment extends to fostering healthcare knowledge through educational grants for clinicians and scientists, advancing rare disease understanding, and enhancing community well-being.
Ultragenyx's grant program focuses on funding educational, clinical, technical, and scientific projects related to rare diseases. It supports accredited and non-accredited programs for healthcare providers, patient advocacy initiatives, scientific meetings, disease awareness campaigns, research, medical publications, fellowships, and sponsorships. The program is especially interested in projects concerning X-Linked Hypophosphatemia, Tumor Induced Osteomalacia, Mucopolysaccharidosis Type VII, Long Chain Fatty-Acid Oxidation Disorders, Homozygous Familial Hypercholesterolemia, and more. Furthermore, Ultragenyx's global philanthropy emphasizes STEAM education, supporting the rare disease community, equitable healthcare access, and emergency relief aid.